Connect with us

Hi, what are you looking for?


Zimbabwe approves long-acting HIV prevention drug

Zimbabwe has become the first county in Africa to approve a long-acting injectable drug that prevents HIV transmission.

The first two injections of Cabotegraviror CAB-LA are administered four weeks apart, followed by an injection every eight weeks.

The drug has received regulatory approval in two other countries, the US and Australia.

Advertisement. Scroll to continue reading.

Zimbabwe will begin rolling out the drug after regulators approved its use. The authorities say it will provide a crucial layer of protection for risk groups.

Large scale studies of the drug showed 79% reduction in HIV risk compared with oral pre-exposure prophylaxis, according to the World Health Organisation.

Zimbabwe approved a long-acting HIV preventative vaginal ring earlier this year.

While African countries have dramatically reduced the number of new HIV infections, adolescent girls and young women remain at risk accounting for 63% of new infections last year.

Advertisement. Scroll to continue reading.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The president of the Zimbabwe Miners Federation, Henrietta Rushwaya, who is a niece of President Emmerson Mnangagwa, has been convicted by a court of...


Zimbabweans on social media are questioning why a man accused of running a visa scam has been released on bail. Tatenda MacDonald Mfende appeared...


Up-and-coming Zimbabwean musician Ashta Eez has told the BBC how being one of the very few African perfomers in Poland has been great for...


Zimbabwe’s President Emmerson Mnangagwa has been accused of nepotism after appointing his son as one of a new set of ministers following his controversial...

Copyright © 2018-2023 The African Press